# I-DROP MGD Symptomatic Relief and Tear Film Stability

> **NCT05011708** · NA · COMPLETED · sponsor: **I-MED Pharma** · enrollment: 10 (actual)

## Conditions studied

- Dry Eye

## Interventions

- **DEVICE:** I-DROP MGD
- **DEVICE:** Thealoz Duo

## Key facts

- **NCT ID:** NCT05011708
- **Lead sponsor:** I-MED Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-23
- **Primary completion:** 2021-12-15
- **Final completion:** 2022-01-12
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2022-03-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05011708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05011708, "I-DROP MGD Symptomatic Relief and Tear Film Stability". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05011708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*